Ms. Memo: This Week in Women's Rights
May 10, 2023

From the ongoing fight for abortion rights and access, to elections, to the drive for the Equal Rights Amendment, there are a multitude of battles to keep up with. In this weekly roundup, find the absolute need-to-know news for feminists.

Healthcare Providers File Federal Lawsuit to Expand Abortion Pill Access [[link removed]]
Mifepristone (Mifeprex) and misoprostol. There are two different ways to have a medication abortion and end a pregnancy: using two different medicines, mifepristone and misoprostol, or using only misoprostol. (Robyn Beck / AFP via Getty Images)
BY CARRIE N. BAKER | On May 8, abortion providers in Virginia, Montana and Kansas filed a federal lawsuit against the Food and Drug Administration (FDA) seeking an order to maintain and expand access to mifepristone, one of two drugs commonly used for early abortion and miscarriage.
The lawsuit, filed by the Center for Reproductive Rights (CRR), comes in response to legal uncertainty caused by a Texas court ruling voiding FDA approval of mifepristone and a dueling Washington court order requiring the FDA to maintain access to the medication. Then the Fifth Circuit severely restricted access to mifepristone in an appeal of the Texas order. On April 14, the Supreme Court halted enforcement of these orders while the Fifth Circuit considers the merits of an appeal of the Texas decision. Medication abortion accounts for more than half of all facility-based abortion care in the United States.
“It is critical that abortion providers and patients obtain certainty in light of the chaos that is currently surrounding mifepristone,” said Nancy Northup, president and CEO of CRR. “We are suing on behalf of abortion providers in states where abortion access remains, but healthcare practitioners need protection for providing medication abortion.”
“We are tired, and we are angry, and we will not compromise or sit idly by as anti-abortion opportunists continue to attempt to block the safest, most effective, and preferred method of medication abortion in this country,” said Amy Hagstrom Miller, president & CEO of Whole Woman’s Health and Whole Woman’s Health Alliance. “Our patients deserve every single option that is available to them as they are making these choices for themselves and their families.”
(Click here to read more) [[link removed]]

Read more
Miles Apart: Texas and California Lawmakers Stake Opposite Corners of Abortion Policy [[link removed]]
Three Reasons Congress Should Reject Medicaid Work Requirements [[link removed]]
The Army Allows Soldiers Charged With Violent Crimes to Leave the Military, Rather Than Face Trial [[link removed]]
The Ongoing Mifepristone Legal Battle Goes Against Everything We Learn in Medical School [[link removed]]

[link removed] [[link removed]] Tune in for a new episode of Ms. magazine's podcast, On the Issues with Michele Goodwin on Apple Podcasts [[link removed]] + Spotify [[link removed]] .
In this episode, Dr. Goodwin is joined by law professor and author Dr. Julie Suk to discuss her urgent, new book, After Misogyny: How the Law Fails Women and What To Do About It , and explore how turning a lens on misogyny can help us to better understand the social, political, and legal challenges of these times. In the face of these challenges, how can women fight back?
We hope you'll listen, subscribe, rate and review today!

[link removed] [[link removed]]

READ THE REST [[link removed]] | GET THE MAGAZINE [[link removed]] | SUPPORT MS. [[link removed]]
[[link removed]]
[link removed] [[link removed]] [link removed] [[link removed]] [link removed] [[link removed]]

Enjoy this newsletter? Forward to a friend!
Was this email forwarded to you by a friend? Subscribe [[link removed]] .

Ms. Magazine
1600 Wilson Boulevard
Suite 801
Arlington, VA 22209
United States
If you believe you received this message in error or wish to no longer receive email from us, please
unsubscribe: [link removed] .